Valuation: AtriCure, Inc.

Market Cap 2.22B 1.92B 1.8B 1.64B 3.09B 211B 3.14B 21.16B 8.28B 106B 8.32B 8.14B 353B P/E 2026 *
413x
P/E 2027 * 104x
Enterprise Value 2.06B 1.79B 1.68B 1.53B 2.87B 197B 2.92B 19.71B 7.71B 98.69B 7.75B 7.58B 329B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.93x
Free-Float
96.19%
Yield 2026 *
-
Yield 2027 * -
1 day-0.16%
1 week+10.55%
Current month+15.17%
1 month+26.87%
3 months+62.94%
6 months+36.76%
Current year+9.93%
1 week 39.45
Extreme 39.45
44.38
1 month 31.9
Extreme 31.895
44.38
Current year 25.36
Extreme 25.36
44.38
1 year 25.36
Extreme 25.36
44.38
3 years 18.94
Extreme 18.94
52.34
5 years 18.94
Extreme 18.94
89.18
10 years 14.36
Extreme 14.355
89.18
Manager TitleAgeSince
Chief Executive Officer 55 2012-11-01
Director of Finance/CFO 48 2014-06-30
Chief Tech/Sci/R&D Officer 59 2017-07-17
Director TitleAgeSince
Director/Board Member 55 2012-11-01
Director/Board Member 64 2013-03-10
Director/Board Member 75 2016-11-09
Date Insider Type Main position Quantity % Market Cap.
8/5/26 Sell

Director

-3,500 0.0069%
8/5/26 Sell

Director

-3,564 0.0070%
7/30/26 Don

Chief Executive Officer

-4,700 0.0092%
Change 5-day change 1-year change 3-year change Capi.($)
-0.16%+10.55%+21.34%-15.91% 2.22B
+0.32%+5.26%-15.07%+5.66% 192B
-0.20%+5.34%-1.63%+8.54% 116B
-1.32%-2.27%+7.21%+65.45% 59.95B
+2.11%+2.55%+34.34%+62.10% 54.64B
-0.88%+6.63%-6.66%-35.54% 50B
+0.75%+10.67%+14.11%-18.09% 34.26B
+0.23%-2.96% - - 31.15B
-1.74%-1.38%+44.29%-12.31% 24.79B
+0.85%+14.53%-3.89%+20.23% 24.07B
Average -0.02%+4.88%+10.45%+8.90% 58.92B
Weighted average by Cap. +0.00%+4.30%+0.77%+12.80%

Financials

2026 *2027 *
Net sales 606M 526M 494M 450M 845M 57.85B 859M 5.79B 2.26B 28.99B 2.28B 2.23B 96.68B 680M 589M 553M 504M 947M 64.86B 963M 6.49B 2.54B 32.5B 2.55B 2.5B 108B
Net income 7.11M 6.17M 5.79M 5.27M 9.91M 679M 10.07M 67.92M 26.57M 340M 26.7M 26.12M 1.13B 20.78M 18.02M 16.91M 15.41M 28.94M 1.98B 29.43M 198M 77.61M 994M 77.99M 76.3M 3.31B
Net Debt -152M -132M -124M -113M -212M -14.52B -215M -1.45B -568M -7.27B -571M -559M -24.26B -226M -196M -184M -168M -315M -21.6B -321M -2.16B -845M -10.82B -850M -831M -36.09B
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
26-08-13 US$43.49 -0.16% 549,779
26-08-12 US$43.56 +1.42% 473,251
26-08-11 US$42.95 +3.15% 562,463
26-08-10 US$41.64 +0.60% 529,526
26-08-07 US$41.39 +4.81% 527,762
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
43.49USD
Average target price
47.33USD
Spread / Average Target
+8.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock